Eyawo Oghenowede, Lyzwinski Lynnette Nathalie, Ugoji Uchechukwu Chidiebere, Pan Shenyi, Sorkpor Setor Kofi, Tawari-Fufeyin Prekeyi, Hogg Robert S
School of Global Health, York University, Toronto, ON, Canada
Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
BMJ Open. 2025 Jan 25;15(1):e089507. doi: 10.1136/bmjopen-2024-089507.
Non-adherence to tuberculosis (TB) treatment poses a significant challenge to effective TB management globally and is a major contributor to the emergence of multidrug-resistant TB. Although adherence to TB treatment has been widely studied, a comprehensive evaluation of the comparative levels of adherence in high- versus low-TB burden settings remains lacking. The objective of this systematic review and meta-analysis is to assess the levels of adherence to TB treatment in high-TB burden countries compared to low-burden countries. Additionally, it seeks to identify the unique facilitators and barriers to treatment adherence in these distinct settings.
This systematic review and meta-analysis will be conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses Protocols Statement. Using key medical subject heading terms and free-text terms related to TB treatment adherence, a systematic search of the literature will be performed in Medline, Embase, CINAHL, Scopus, Global Health and the Cochrane Databases of Systematic Reviews. A medical librarian will assist with developing the search strategy. Two independent reviewers will independently screen studies against predefined inclusion and exclusion criteria at both the title/abstract and full-text stages. Working in duplicate, the same two reviewers will independently extract relevant study and outcomes data, including study descriptors, TB burden, adherence levels and adherence measures, from eligible studies. Countries will be classified according to TB burden based on the WHO's high-burden country list from the post-2015 era (2015-2025). The quality of the included studies will be appraised using the Cochrane Risk of Bias tool and the Newcastle-Ottawa Scale. Qualitative data will be appraised using the Critical Appraisal Skills Programme tool. Studies will be pooled using the DerSimonian-Laird random-effects meta-analysis. Additionally, a meta-synthesis of the qualitative data from the included studies may be conducted to identify emergent themes related to facilitators and barriers of TB treatment adherence in high- vs low-TB burden countries.
Ethics approval is not required for this study as it does not involve the recruitment or collection of data from participants. The findings from this systematic review and meta-analysis will be disseminated through publication in peer-reviewed journals, presentations at scientific conferences, and via social media channels to enhance visibility, particularly within programmatic and policy spheres.
CRD42021273336.
不坚持结核病治疗对全球结核病的有效管理构成重大挑战,也是耐多药结核病出现的主要原因。尽管对结核病治疗的依从性已进行了广泛研究,但仍缺乏对高结核病负担地区与低结核病负担地区依从性比较水平的全面评估。本系统评价和荟萃分析的目的是评估高结核病负担国家与低负担国家结核病治疗的依从性水平。此外,它旨在确定在这些不同环境中影响治疗依从性的独特促进因素和障碍。
本系统评价和荟萃分析将按照系统评价和荟萃分析方案声明的首选报告项目进行。使用与结核病治疗依从性相关的关键医学主题词和自由文本词,在Medline、Embase、CINAHL、Scopus、Global Health和Cochrane系统评价数据库中对文献进行系统检索。一名医学图书馆员将协助制定检索策略。两名独立评审员将在标题/摘要和全文阶段根据预定义的纳入和排除标准独立筛选研究。同样由这两名评审员重复操作,独立从符合条件的研究中提取相关的研究和结果数据,包括研究描述符、结核病负担、依从性水平和依从性测量方法。将根据世界卫生组织2015年后时代(2015 - 2025年)的高负担国家名单,按结核病负担对国家进行分类。将使用Cochrane偏倚风险工具和纽卡斯尔 - 渥太华量表评估纳入研究的质量。将使用批判性评估技能计划工具评估定性数据。将使用DerSimonian - Laird随机效应荟萃分析对研究进行汇总。此外,可能会对纳入研究的定性数据进行荟萃综合分析,以确定高结核病负担国家与低负担国家中与结核病治疗依从性促进因素和障碍相关的新出现主题。
本研究无需伦理批准,因为它不涉及从参与者那里招募或收集数据。本系统评价和荟萃分析的结果将通过在同行评审期刊上发表、在科学会议上展示以及通过社交媒体渠道进行传播,以提高知名度,特别是在项目和政策领域。
PROSPERO注册号:CRD42021273336。